153 related articles for article (PubMed ID: 20355241)
1. Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.
Thanasai J; Limpaiboon T; Jearanaikoon P; Sripa B; Pairojkul C; Tantimavanich S; Miwa M
World J Gastroenterol; 2010 Apr; 16(13):1631-8. PubMed ID: 20355241
[TBL] [Abstract][Full Text] [Related]
2. Thymidine phosphorylase promotes angiogenesis and tumour growth in intrahepatic cholangiocarcinoma.
Li S; Yang H; Li K; Fan G; Deng L; Xu C
Cell Biochem Funct; 2020 Aug; 38(6):743-752. PubMed ID: 32476180
[TBL] [Abstract][Full Text] [Related]
3. Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.
Seeliger H; Guba M; Koehl GE; Doenecke A; Steinbauer M; Bruns CJ; Wagner C; Frank E; Jauch KW; Geissler EK
Clin Cancer Res; 2004 Mar; 10(5):1843-52. PubMed ID: 15014039
[TBL] [Abstract][Full Text] [Related]
4. Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
[TBL] [Abstract][Full Text] [Related]
5. Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
Jaidee R; Kongpetch S; Senggunprai L; Prawan A; Kukongviriyapan U; Kukongviriyapan V
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1681-1690. PubMed ID: 32383028
[TBL] [Abstract][Full Text] [Related]
6. The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
Matsushita S; Ikeda R; Nishizawa Y; Che XF; Furukawa T; Miyadera K; Tabata S; Ushiyama M; Tajitsu Y; Yamamoto M; Takeda Y; Minami K; Mataki H; Kanzaki T; Yamada K; Kanekura T; Akiyama S
Int J Oncol; 2010 May; 36(5):1193-200. PubMed ID: 20372793
[TBL] [Abstract][Full Text] [Related]
7. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
Srijiwangsa P; Ponnikorn S; Na-Bangchang K
BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway.
Liu W; Zhang J; Yao X; Jiang C; Ni P; Cheng L; Liu J; Ni S; Chen Q; Li Q; Zhou K; Wang G; Zhou F
Cancer Sci; 2018 Oct; 109(10):3294-3304. PubMed ID: 30151975
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
[TBL] [Abstract][Full Text] [Related]
10. Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis.
Marchetti S; Chazal M; Dubreuil A; Fischel JL; Etienne MC; Milano G
Br J Cancer; 2001 Aug; 85(3):439-45. PubMed ID: 11487278
[TBL] [Abstract][Full Text] [Related]
11. NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway.
Ge X; Wang Y; Li Q; Yu H; Ji G; Miao L
Oncol Rep; 2013 Jul; 30(1):448-54. PubMed ID: 23619566
[TBL] [Abstract][Full Text] [Related]
12. The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinoma.
Aishima S; Taguchi K; Sugimachi K; Asayama Y; Nishi H; Shimada M; Sugimachi K; Tsuneyoshi M
Int J Surg Pathol; 2002 Jan; 10(1):47-56. PubMed ID: 11927969
[TBL] [Abstract][Full Text] [Related]
13. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: in vitro and in vivo study.
Evrard A; Cuq P; Robert B; Vian L; Pèlegrin A; Cano JP
Int J Cancer; 1999 Jan; 80(3):465-70. PubMed ID: 9935191
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase expression in invasive carcinoma: correlations with clinicopathologic variables and in vitro chemosensitivity to 5-fluorouracil.
Yang Q; Shan L; Yoshimura G; Taniguchi E; Suzuma T; Nakamura Y; Nakamura M; Utsunomiya H; Tang W; Sakurai T; Kakudo K
Anticancer Res; 1999; 19(6C):5543-6. PubMed ID: 10697613
[TBL] [Abstract][Full Text] [Related]
16. Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells.
Guo SS; Wang Y; Fan QX
World J Gastroenterol; 2019 Jul; 25(26):3380-3391. PubMed ID: 31341363
[TBL] [Abstract][Full Text] [Related]
17. Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.
Bijnsdorp IV; Capriotti F; Kruyt FA; Losekoot N; Fukushima M; Griffioen AW; Thijssen VL; Peters GJ
Br J Cancer; 2011 Mar; 104(7):1185-92. PubMed ID: 21386840
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase expression in oral squamous cell carcinoma.
Yao L; Itoh S; Furuta I
Oral Oncol; 2002 Sep; 38(6):584-90. PubMed ID: 12167436
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled uracil derivative as a novel SPECT probe for thymidine phosphorylase: suppressed accumulation into tumor cells by target gene knockdown.
Li H; Zhao S; Jin Y; Nishijima K; Akizawa H; Ohkura K; Tamaki N; Kuge Y
Nucl Med Commun; 2011 Dec; 32(12):1211-5. PubMed ID: 21934548
[TBL] [Abstract][Full Text] [Related]
20. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
